Sclerosis multiplex (SM): nyitott vizsgálatok itt: Brazília

5 nyitott vizsgálatnak van helyszíne itt: Brazília. Regiszteradat; hogy ki vehet részt, azt csak a vizsgálat csapata dönti el.

NCT06846281
Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.
Kísérleti kezelés · 3. fázis · Novartis Pharmaceuticals
Fortaleza · Joinville · Porto Alegre · São Paulo
Regiszter frissítve: 2026-10-26
NCT07161258
A Pharmacokinetics (PK), Pharmacodynamics (PD), Safety and Tolerability Study of Fenebrutinib in Children and Adolescents With Relapsing Multiple Sclerosis (RMS)
Kísérleti kezelés · 2. fázis · Hoffmann-La Roche
L2IP - Instituto de Pesquisas Clínicas Ltda, Brasília · Instituto de Neurologia de Curitiba - Hospital Ecoville, Curitiba · Nucleo de Pesquisa Clinica do Rio Grande do Sul NPCR, Porto Alegre · Centro de Pesquisas Clinicas - CPCLIN, São Paulo
Regiszter frissítve: 2026-10-13
NCT07225504
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
Kísérleti kezelés · 3. fázis · Novartis Pharmaceuticals
Fortaleza · Joinville · Porto Alegre · Rio de Janeiro · Santo André · São Paulo
Regiszter frissítve: 2026-10-13
NCT07325292
Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
Kísérleti kezelés · 3. fázis · Sanofi
L2IP - Instituto de Pesquisas Clínicas- Site Number : 0760003, Brasília · Instituto de Neurologia de Curitiba - Ecoville- Site Number : 0760001, Curitiba · Clínica Neurológica- Site Number : 0760007, Joinville
Regiszter frissítve: 2026-10-13
NCT07282574
A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of RO7268489 as Add-on Therapy to Ocrelizumab, in Participants With Progressive Forms of Multiple Sclerosis (MS)
Kísérleti kezelés · 2. fázis · Hoffmann-La Roche
Centro de Pesquisas Clinicas - CPCLIN, São Paulo
Regiszter frissítve: 2026-10-07

Minden vizsgálat (Sclerosis multiplex (SM)) és a térkép

Ez az oldal nem orvosi tanács. Mielőtt egy vizsgálatot megkeresel, beszélj az orvosoddal.

Hibát jelzek

Sclerosis multiplex (SM): nyitott vizsgálatok itt: Brazília

Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.

A Pharmacokinetics (PK), Pharmacodynamics (PD), Safety and Tolerability Study of Fenebrutinib in Children and Adolescents With Relapsing Multiple Sclerosis (RMS)

A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis

Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis

A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of RO7268489 as Add-on Therapy to Ocrelizumab, in Participants With Progressive Forms of Multiple Sclerosis (MS)